Roche Holding ROP 0.00%increase; up pointing triangle backed its full-year guidance as its pharmaceuticals division helped drive a first-half rise in sales.

The Swiss drugmaker Thursday reported first-half sales of 30.36 billion Swiss francs, equivalent to $37.28 billion. Compared with the same period a year earlier, sales grew 6% on a constant exchange rate basis and exceeded the 30.27 billion Swiss francs analysts had expected, according to a company compiled consensus.

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8